Skip to main content

Metropolis Healthcare Ltd

NSE: METROPOLIS BSE: 542650Healthcare

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

509
52W: ₹400 — ₹600
PE 64.9 · Book ₹64 · +695% vs book
Market Cap₹10,561 Cr
Stock P/E64.9Price to Earnings
ROCE16.8%Return on Capital
ROE13.1%Return on Equity
Div. Yield0.39%Face Value ₹2

Weaknesses

  • Stock is trading at 8.00 times its book value
  • The company has delivered a poor sales growth of 10.8% over past five years.
  • Company has a low return on equity of 11.8% over last 3 years.
  • Dividend payout has been low at 5.90% of profits over last 3 years

Shareholding Pattern

Promoters48.86%
FIIs10.43%
DIIs35.8%
Public4.92%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters49.62%49.43%0.249.4%0.048.89%0.548.89%48.89%48.87%0.048.86%0.0
FIIs18.25%18.56%0.316.73%1.815.29%1.412.83%2.512.52%0.311.68%0.810.43%1.3
DIIs27.42%28.02%0.630%2.030.3%0.332.4%2.133.1%0.734.73%1.635.8%1.1
Public4.69%3.98%0.73.86%0.15.51%1.65.87%0.45.48%0.44.69%0.84.92%0.2

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales269292286322297312324356335352
Expenses211218218240232259247264255262
Operating Profit59746882655377918090
OPM %22%25%24%26%22%17%24%26%24%26%
Net Profit27323142272436473243
EPS ₹1.31.551.532.061.341.151.722.251.552.09

AI Insights

Revenue Trend

Mar 2026 revenue at ₹1,365Cr, up 12.2% YoY. OPM at 25%.

Debt Position

Borrowings at ₹152Cr. Debt-to-equity ratio: 0.12x. Healthy balance sheet.

Institutional Flow

DIIs: 35.8% (+20.91pp change). FIIs: 10.43% (-15.23pp change). Promoters hold 48.86%.

Margin & Efficiency

ROCE declining from 22% (Mar 2015) to 0% (Mar 2026). Working capital days: 0.

Valuation

PE 64.9x with 16.8% ROCE. Price is 695% above book value of ₹64. Dividend yield: 0.39%.

Recent Announcements